Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in mice
about
Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agentsVaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in miceRecombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).Interleukin-15 and its receptor augment dendritic cell vaccination against the neu oncogene through the induction of antibodies partially independent of CD4 help.Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeys.Development of a highly efficacious vaccinia-based dual vaccine against smallpox and anthrax, two important bioterror entitiesEvaluation of the potency of the anti-idiotypic antibody Ab2/3H6 mimicking gp41 as an HIV-1 vaccine in a rabbit prime/boost studyVaccinomics: current findings, challenges and novel approaches for vaccine developmentViral vector-based therapeutic cancer vaccinesEnhancing poxvirus vectors vaccine immunogenicity.A multi-valent vaccinia virus-based tuberculosis vaccine molecularly adjuvanted with interleukin-15 induces robust immune responses in miceHuman leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine.Attenuation and immunogenicity of host-range extended modified vaccinia virus Ankara recombinants.Vaccinia virus vaccines: past, present and future.Myxoma virus expressing interleukin-15 fails to cause lethal myxomatosis in European rabbits.Distinct roles for IL-2 and IL-15 in the differentiation and survival of CD8+ effector and memory T cells.Challenges and Achievements in Prevention and Treatment of Smallpox.Personalized vaccines: the emerging field of vaccinomics
P2860
Q28384852-4A74BC3F-161F-4E3E-98B1-650A86E647DCQ30375085-5DB5A323-0514-436C-BFA3-4CC997F14950Q33320536-F59E6C5B-6604-4B35-BC65-B6245F5B82BBQ33638464-47957CB7-455E-407F-928A-8EE2065751DCQ34188464-4D4D699C-5055-45DF-83E9-6EFDC0A23149Q34241550-BD909044-076B-498D-ABAA-B4A64AAC2F38Q34312108-3B0F3A5D-75C3-40E5-A346-DE60E4881078Q35176899-1D1CA345-95CD-4220-AAD6-47B9DF93ED8FQ35515080-C0CA6FA6-4C41-4E63-9601-4C99C50770AAQ36978452-5758A377-6A0C-4EB4-93D8-858A7F74C881Q37155566-3C68E113-434E-48A5-8AAF-23354F15F6B4Q37158293-3B2CC74F-171D-47BA-9004-DC778C4DB9A7Q37209483-DE8F58E2-EE2A-4730-9088-9686D303390AQ37343595-AFF1E0F5-1E9E-4A2D-B375-25CBFBC36DFDQ39995833-ED4B9695-E275-4E48-A543-3542875AE44AQ42128057-0DB85130-3E26-473A-B54E-2C143EC008B3Q47547852-0CBFB343-6E41-4D9E-928D-AB1F801F9525Q57157844-8400DF5E-E664-43E9-8D2F-F9E8B495F2DE
P2860
Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in mice
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Development of smallpox vaccin ...... , efficacy, and safety in mice
@ast
Development of smallpox vaccin ...... , efficacy, and safety in mice
@en
type
label
Development of smallpox vaccin ...... , efficacy, and safety in mice
@ast
Development of smallpox vaccin ...... , efficacy, and safety in mice
@en
prefLabel
Development of smallpox vaccin ...... , efficacy, and safety in mice
@ast
Development of smallpox vaccin ...... , efficacy, and safety in mice
@en
P2093
P2860
P356
P1433
P1476
Development of smallpox vaccin ...... , efficacy, and safety in mice
@en
P2093
Jay A Berzofsky
Joseph D Mosca
Liyanage P Perera
Nicole Baldwin
Sang-Kon Oh
Thomas A Waldmann
P2860
P304
P356
10.1128/JVI.00538-07
P407
P577
2007-06-06T00:00:00Z